Parkinson's disease (PD) is a progressive neurodegenerative disorder for which there is as yet no cure. It affects many aspects of patients' lives, only some of which can be monitored by available clinical rating scales. In the past decade, there has been a new emphasis on the use of health-related
Nonmotor symptoms are independently associated with impaired health-related quality of life in Chinese patients with Parkinson's disease
✍ Scribed by Huijuan Li; Meifen Zhang; Ling Chen; June Zhang; Zhong Pei; Ailing Hu; Qing Wang
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 83 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
We performed a cross‐sectional study of 82 Chinese patients with Parkinson's disease (PD) enrolled during an 18‐month period using a clinical interview to assess the prevalence of nonmotor symptoms (NMS), the association with disease severity and motor status, and the impact on patients' health‐related quality of life (Hr‐QoL). The patients' NMS, Hr‐QoL, disease severity, and motor status were assessed by the Nonmotor Symptoms Scale (NMSS), the 39‐item Parkinson's Disease Questionnaire (PDQ‐39), the modified Hoehn and Yahr staging scale (H&Y) and the Unified Parkinson's Disease Rating Scale part III (UPDRS III), respectively. We found that 100% of patients with PD presented with NMS. The NMSS significantly correlated with disease duration (Spearman's r~S~ = 0.276, P = 0.012), H&Y (r~S~ = 0.230, P = 0.038), and UPDRS III (r~S~ = 0.350, P = 0.001). Similarly, the PDQ‐39 SI significantly associated with the disease duration (r~S~ = 0.258, P = 0.019), H&Y (r~S~ = 0.340, P = 0.002), and UPDRS III (r~S~ = 0.453, P < 0.001). NMS domains that influenced the PDQ‐39 SI were sleep/fatigue, mood, gastrointestinal, urinary, and miscellaneous symptoms. This strongly suggested that the five domains played a key role in the manifestation of Hr‐QoL. NMSS explains more of the variability in Hr‐QoL than UPDRS III, when both are the model (stepwise multiple linear regression analysis R^2^ change, 47.8% vs. 5.87%, respectively). Therefore, these findings demonstrate that NMS are independently and negatively associated with Hr‐QoL in PD and that improving NMS should be viewed as an important part in the management of PD. © 2010 Movement Disorder Society
📜 SIMILAR VOLUMES
## Background: Infliximab induces remission and improves the health-related quality of life (hrqol) of patients with refractory or fistulous crohn's disease (cd). however, little information is available as to whether its effect on hrqol is sustained over time. the objective was to measure the hrqo
## Background: To explore the relationship between personality and disease-specific quality of life [Inflammatory Bowel Disease Questionnaire (IBDQ)] in distressed [Perceived Stress Questionnaire (PSQ)] patients with ulcerative colitis (UC) and Crohn's disease (CD). Methods: Included in the study
## Abstract ## Objective To assess the impact of cyclophosphamide (CYC) on the health‐related quality of life (HRQOL) of patients with scleroderma after 12 months of treatment. ## Methods One hundred fifty‐eight subjects participated in the Scleroderma Lung Study, with 79 each randomized to CYC